Nuclea Biotechnologies Inc.-Medical Equipment-Deals and Alliances Profile

Nuclea Biotechnologies Inc.-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME186470D
  • |
  • Pages: 35
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Nuclea Biotechnologies Inc. (Nuclea) is a healthcare center that develops and commercializes clinical diagnostic assays identifying gene and protein expression profiles. The center develops IVD and RUO diagnostic assays and kits for the early detection and monitoring of biomarkers in oncology and endocrinology. It provides CLIA tests for proteins associated with cancer and other chronic diseases. Nuclea provides clia lab and biomarker services. It conducts research on molecular oncology therapeutics and diagnostics for the pharmaceutical and biotechnology industries. The center partners with various institutes, medical centers and medical universities. Nuclea is headquartered in Pittsfield, Massachusetts, the US.

Nuclea Biotechnologies Inc.-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Nuclea Biotechnologies Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5

Nuclea Biotechnologies Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 6

Nuclea Biotechnologies Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7

Nuclea Biotechnologies Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 8

Nuclea Biotechnologies Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 9

Nuclea Biotechnologies Inc., Medical Equipment, Deal Details 11

Asset Purchase 11

Wilex Acquires Oncogene Science Assets From Siemens Healthcare Diagnostics 11

Venture Financing 12

Nuclea Biotechnologies Raises USD 4.2 Million In Series D Financing 12

Nuclea Biotechnologies Raises USD 1.1 Million In Venture Financing 13

Nuclea Biotechnologies Raises USD 5 Million In Series C Financing 14

Nuclea Biotech Raises USD 0.6 Million In Venture Financing 15

Nuclea Biotechnologies Raises USD 1.9 Million in Venture Financing 16

Nuclea Biotechnologies Raises Additional USD 1.4 Million In Series B Financing 17

Nuclea Biotechnologies Secures USD 5.5 Million In Financing Round 18

Partnerships 19

Nuclea Biotech Enters into Joint Development Partnership with Aelan Cell Technologies 19

Nuclea Biotech Enters into Co-Development Agreement with Thermo Fisher Scientific 20

Enzo Clinical Labs And Nuclea Biotech Enter Into Agreement To Market Breast Cancer Test 21

Nuclea Biotech Enters Into Co-Development Agreement With AccuGenomics 22

Nuclea Biotech Enters Into Co-Development Agreement With Nuvera 23

Nuclea Biotech Enters Into Research Agreement With College of Nanoscale Science For Cancer Diagnosis 24

Nuclea Biotech Enters Into Research Agreement With Berkshire Medical Center For Cancer Biomarkers 25

Wilex And Nuclea Biotechnologies Enter Into Agreement For Serum HER-2/Neu ELISA Test 26

Wilex Enters Into Co-Marketing Agreement With Immuno-Biological Labs For Portfolio Of Biomarker Tests 27

Wilex Enters Into Distribution Agreement With GeneDiagnostics For Serum HER-2/neu Test 28

WILEX Enters Into Co-Marketing Agreement With ALPCO Diagnostics 29

Nuclea Biotechnologies Enters Into Partnership With Boston Medical Center 30

Acquisition 31

Nuclea Biotechnologies Acquires Wilex 31

Nuclea Biotechnologies Inc.-Key Competitors 32

Key Employees 33

Locations And Subsidiaries 34

Head Office 34

Other Locations & Subsidiaries 34

Appendix 35

Methodology 35

About GlobalData 35

Contact Us 35

Disclaimer 35

List of Figures

Nuclea Biotechnologies Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 1

Nuclea Biotechnologies Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 1

Nuclea Biotechnologies Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 1

Nuclea Biotechnologies Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 1

Nuclea Biotechnologies Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5

Nuclea Biotechnologies Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 6

Nuclea Biotechnologies Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7

Nuclea Biotechnologies Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016 8

List of Tables

Nuclea Biotechnologies Inc., Medical Equipment, Key Facts 1

Nuclea Biotechnologies Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 1

Nuclea Biotechnologies Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5

Nuclea Biotechnologies Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 6

Nuclea Biotechnologies Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7

Nuclea Biotechnologies Inc., Deals By Market, 2010 to YTD 2016 8

Nuclea Biotechnologies Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 9

Wilex Acquires Oncogene Science Assets From Siemens Healthcare Diagnostics 11

Nuclea Biotechnologies Raises USD 4.2 Million In Series D Financing 12

Nuclea Biotechnologies Raises USD 1.1 Million In Venture Financing 13

Nuclea Biotechnologies Raises USD 5 Million In Series C Financing 14

Nuclea Biotech Raises USD 0.6 Million In Venture Financing 15

Nuclea Biotechnologies Raises USD 1.9 Million in Venture Financing 16

Nuclea Biotechnologies Raises Additional USD 1.4 Million In Series B Financing 17

Nuclea Biotechnologies Secures USD 5.5 Million In Financing Round 18

Nuclea Biotech Enters into Joint Development Partnership with Aelan Cell Technologies 19

Nuclea Biotech Enters into Co-Development Agreement with Thermo Fisher Scientific 20

Enzo Clinical Labs And Nuclea Biotech Enter Into Agreement To Market Breast Cancer Test 21

Nuclea Biotech Enters Into Co-Development Agreement With AccuGenomics 22

Nuclea Biotech Enters Into Co-Development Agreement With Nuvera 23

Nuclea Biotech Enters Into Research Agreement With College of Nanoscale Science For Cancer Diagnosis 24

Nuclea Biotech Enters Into Research Agreement With Berkshire Medical Center For Cancer Biomarkers 25

Wilex And Nuclea Biotechnologies Enter Into Agreement For Serum HER-2/Neu ELISA Test 26

Wilex Enters Into Co-Marketing Agreement With Immuno-Biological Labs For Portfolio Of Biomarker Tests 27

Wilex Enters Into Distribution Agreement With GeneDiagnostics For Serum HER-2/neu Test 28

WILEX Enters Into Co-Marketing Agreement With ALPCO Diagnostics 29

Nuclea Biotechnologies Enters Into Partnership With Boston Medical Center 30

Nuclea Biotechnologies Acquires Wilex 31

Nuclea Biotechnologies Inc., Key Competitors 32

Nuclea Biotechnologies Inc., Key Employees 33

Nuclea Biotechnologies Inc., Other Locations 34

Nuclea Biotechnologies Inc., Subsidiaries 34

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Nuclea Biotechnologies Inc., Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 18138
Site License
USD 500 INR 36275
Corporate User License
USD 750 INR 54413

NEWSLETTER BY CATEGORY




Testimonials

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com